Somatic embryogenesis induction
The experiments were divided into individual treatments or combinations of auxins and cytokinin (BAP, 2,4-D, and NAA). It was observed that though all the concentrations of BAP (when used alone) were significantly effective for callus formation, were unresponsive for somatic embryo formation. The maximum callogenic frequency (95.37 ± 2.44%) was obtained at 0.1 mg/l BAP (Fig. 2). The individual treatment with auxins either 2,4-D or NAA, was found effective (at significance p < 0.05) for induction of somatic embryogenesis. The maximum callogenic frequency (95.37 ± 2.44%) obtained at 1 mg/l 2,4-D showed the least frequency of embryogenic callus formation (19.44 ± 2.77%). On the contrary, the callogenic frequency obtained at 4 mg/l 2,4-D was 67.13 ± 2.82%, but it was more significant for embryogenic callus formation with 58.33 ± 4.81% frequency (Fig. 3A and 3B). NAA was found significantly productive for somatic embryogenesis at 2 mg/l and 4 mg/l concentration (Fig. 4A and 4B). The MS basal media without any growth regulator (control) was not significant in forming both non-embryogenic or embryogenic callus. Among all individually tested growth regulators, 4 mg/l 2,4-D proved to be significantly more efficient for induction of somatic embryogenesis.
The combination of cytokinin BAP with auxin 2,4-D or NAA was also tested for somatic embryogenesis induction. The maximum callogenic frequency (82.41 ± 4.04%) was obtained at 0.1 mg/l BAP + 2 mg/l 2,4-D (Table 1). The highest embryogenic frequency (69.44 ± 2.77%) was obtained at 0.1 mg/l BAP + 2 mg/l 2,4-D which do not differ significantly from the result obtained at 0.1 mg/l BAP + 4 mg/l 2,4-D (Table 1). Independent of the concentrations of BAP used (0.01 and 0.1 mg/l), the presence of 2,4-D (1, 2, and 4 mg/l) or NAA (2 and 4 mg/l) significantly (p < 0.05) increased the frequencies of embryogenic induction, except for the combination 0.01 mg/l BAP + 4 mg/l 2,4-D (Table 1). Combining the three growth regulators significantly (p < 0.05) decreased the embryogenic frequency. The individual and combination treatments were responsive for callus induction with the frequency range between 36–97%. The combination of BAP with either 2,4-D or NAA was more efficient for somatic embryogenesis induction than their individual or triple combination treatment.
Table 1
Influence of combination of BAP × 2,4-D, BAP × NAA, and BAP × 2,4-D × NAA on frequency of callogenesis and somatic embryogenesis, somatic embryo maturation and conversion to plantlets
Growth regulators (mg/l) | Frequency of callogenesis (%) | Frequency of embryogenesis (%) | Average No. of Advanced stage embryos per treatments | Average No. of plantlets per treatments (after transferring to MS basal) |
BAP | 2,4-D | NAA |
0.00 | 0.00 | 0.00 | 0.00 ± 0.00i | 0.00 ± 0.00h | 0.00 ± 0.00h | 0.00 ± 0.00h |
0.01 | 1.00 | 0.00 | 73.15 ± 0.93bc | 50.00 ± 4.80c | 1.83 ± 0.05c | 0.85 ± 0.02ef |
0.01 | 2.00 | 0.00 | 71.30 ± 2.45bc | 61.11 ± 2.78ab | 2.62 ± 0.10a | 1.08 ± 0.05bcd |
0.01 | 4.00 | 0.00 | 69.45 ± 2.78bc | 52.77 ± 2.77bc | 2.84 ± 0.09a | 1.24 ± 0.05ab |
0.01 | 0.00 | 2.00 | 50.00 ± 3.21def | 36.11 ± 2.78e | 1.00 ± 0.08f | 0.92 ± 0.12de |
0.01 | 0.00 | 4.00 | 60.19 ± 3.34cd | 47.22 ± 2.77cd | 1.84 ± 0.08c | 0.94 ± 0.04cde |
0.01 | 1.00 | 2.00 | 63.89 ± 2.78cd | 38.89 ± 2.78de | 2.22 ± 0.10b | 1.07 ± 0.06bcd |
0.01 | 2.00 | 2.00 | 58.33 ± 4.81cd | 13.89 ± 2.78g | 0.91 ± 0.03fg | 0.48 ± 0.04g |
0.01 | 1.00 | 4.00 | 72.22 ± 2.77bc | 36.11 ± 2.78e | 1.65 ± 0.06cd | 0.68 ± 0.04f |
0.01 | 2.00 | 4.00 | 44.44 ± 2.77fgh | 11.11 ± 2.78g | 0.74 ± 0.04g | 0.33 ± 0.03g |
0.10 | 1.00 | 0.00 | 57.41 ± 4.90cd | 50.00 ± 4.80ab | 2.38 ± 0.09b | 1.01 ± 0.07cde |
0.10 | 2.00 | 0.00 | 82.41 ± 4.04a | 69.44 ± 2.77a | 2.85 ± 0.04a | 1.30 ± 0.07a |
0.10 | 4.00 | 0.00 | 75.00 ± 4.81bc | 63.89 ± 2.78a | 2.18 ± 0.04b | 1.13 ± 0.06abc |
0.10 | 0.00 | 2.00 | 75.00 ± 4.81bc | 52.77 ± 5.55bc | 1.54 ± 0.10d | 0.68 ± 0.09f |
0.10 | 0.00 | 4.00 | 72.22 ± 2.78bc | 61.11 ± 2.78ab | 1.11 ± 0.06ef | 0.74 ± 0.04f |
0.10 | 1.00 | 2.00 | 41.66 ± 4.81gh | 25.00 ± 4.80f | 2.13 ± 0.04b | 0.69 ± 0.04f |
0.10 | 2.00 | 2.00 | 47.22 ± 2.77efg | 0.00 ± 0.00h | 0.00 ± 0.00h | 0.00 ± 0.00h |
0.10 | 1.00 | 4.00 | 55.55 ± 2.77cde | 19.44 ± 2.77fg | 1.28 ± 0.15e | 0.32 ± 0.03g |
0.10 | 2.00 | 4.00 | 36.11 ± 2.77h | 0.00 ± 0.00h | 0.00 ± 0.00h | 0.00 ± 0.00h |
Standard errors of means are indicated. Values followed by the same letter are not significantly different by Duncan multiple comparison test (p ≤ 0.05). |
Cream-colored, shiny, translucent, smooth-surfaced, and compact somatic embryos developed through callus formation from the cut edges of the cotyledonary explant. The development of somatic embryos was observed to be initiated by the end of 5th week. Somatic embryo formed and matured asynchronously through various developmental stages; globular (Fig. 1E), heart (Fig. 1F), torpedo (Fig. 1G), and cotyledonary (Fig. 1H). Some treatments, particularly with higher NAA concentration (individually or in combination), resulted in direct shoot formation. The number of somatic embryos (globular-staged) ranged between 1–50 irrespective of the treatments (data not shown).
It was observed that lesser number of globular-staged somatic embryos matured to advanced-staged somatic embryos. The maximum average number of an advanced-stage embryo (1.53 ± 0.04) was obtained at 4 mg/l 2,4-D (Fig. 3B). The NAA produced a maximum of 1.12 ± 0.05 advanced-stage embryo at 4 mg/l (Fig. 4B). Combination of 0.1 mg/l BAP with 2 mg/l 2,4-D produced significantly (p < 0.05) higher (2.85 ± 0.04) number of advanced-stage somatic embryos (Table 1). However, this data did not differ significantly from the data obtained with treatment of 0.01 mg/l BAP + 2 mg/l 2,4-D or 0.01 mg/l BAP + 4 mg/l 2,4-D. The combination of two growth regulators, a cytokinin and an auxin, showed a synergistic effect for the induction and development of somatic embryos.
Our study witnessed the challenges in developmental advancement at various stages from the globular to cotyledonary phase. Efforts to overcome the challenges were unproductive since either the embryos remained non-responsive or turned dark-brown after 2–3 weeks of treatment (data not shown). Though the frequency of somatic embryogenesis obtained was satisfactorily, we observed a reduced conversion to advanced-stage somatic embryos.
Somatic embryo conversion to plantlet
The conversion of somatic embryos of P. santalinus to plantlets were unproductive on the hormonal medium. Therefore cotyledonary-staged embryos were transferred to MS basal medium (Fig. 5A). The somatic embryos were converted into a complete plantlet with concurrent development of shoot and root (Fig. 5B, 5C, and 5D). It was also noticed that sometimes, instead of developing into complete plantlet, the matured embryos only developed either shoots or roots. Transferring embryos from individual PGR treatment to basal media did not support somatic embryo conversion. The plantlets were generated only when embryos were transferred from PGR treatments to basal media with the highest number of average plantlets (1.30 ± 0.07) obtained at 0.1 mg/l BAP + 2 mg/l 2,4-D (Table 1).